166 related articles for article (PubMed ID: 11320117)
1. Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues.
Payton M; Mushtaq A; Yu TW; Wu LJ; Sinclair J; Sim E
Microbiology (Reading); 2001 May; 147(Pt 5):1137-1147. PubMed ID: 11320117
[TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical characterization of an active arylamine N-acetyltransferase possessing a non-canonical Cys-His-Glu catalytic triad.
Kubiak X; Li de la Sierra-Gallay I; Chaffotte AF; Pluvinage B; Weber P; Haouz A; Dupret JM; Rodrigues-Lima F
J Biol Chem; 2013 Aug; 288(31):22493-505. PubMed ID: 23770703
[TBL] [Abstract][Full Text] [Related]
3. Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop.
Rodrigues-Lima F; Deloménie C; Goodfellow GH; Grant DM; Dupret JM
Biochem J; 2001 Jun; 356(Pt 2):327-34. PubMed ID: 11368758
[TBL] [Abstract][Full Text] [Related]
4. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
[TBL] [Abstract][Full Text] [Related]
5. The pharmacogenetics of NAT: structural aspects.
Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E
Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.
Sandy J; Mushtaq A; Holton SJ; Schartau P; Noble ME; Sim E
Biochem J; 2005 Aug; 390(Pt 1):115-23. PubMed ID: 15869465
[TBL] [Abstract][Full Text] [Related]
7. Arylamine N-acetyltransferases: from structure to function.
Sim E; Walters K; Boukouvala S
Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
[TBL] [Abstract][Full Text] [Related]
8. Structure and mechanism of arylamine N-acetyltransferases.
Westwood IM; Kawamura A; Fullam E; Russell AJ; Davies SG; Sim E
Curr Top Med Chem; 2006; 6(15):1641-54. PubMed ID: 16918475
[TBL] [Abstract][Full Text] [Related]
9. From transglutaminases (TGs) to arylamine N-acetyltransferases (NATs): Insight into the role of a spatially conserved aromatic amino acid position in the active site of these two families of enzymes.
Xu X; Zhang W; Berthelet J; Liu R; Michail C; Chaffotte AF; Dupret JM; Rodrigues-Lima F
Biochem Biophys Res Commun; 2020 Apr; 525(2):308-312. PubMed ID: 32089267
[TBL] [Abstract][Full Text] [Related]
10. Arylamine N-acetyltransferases: what we learn from genes and genomes.
Boukouvala S; Fakis G
Drug Metab Rev; 2005; 37(3):511-64. PubMed ID: 16257833
[TBL] [Abstract][Full Text] [Related]
11. The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity.
Mushtaq A; Payton M; Sim E
J Biol Chem; 2002 Apr; 277(14):12175-81. PubMed ID: 11799105
[TBL] [Abstract][Full Text] [Related]
12. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
[TBL] [Abstract][Full Text] [Related]
13. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
14. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
[TBL] [Abstract][Full Text] [Related]
15. In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria.
Rodrigues-Lima F; Dupret JM
Biochem Biophys Res Commun; 2002 May; 293(2):783-92. PubMed ID: 12054539
[TBL] [Abstract][Full Text] [Related]
16. Structure of arylamine N-acetyltransferase reveals a catalytic triad.
Sinclair JC; Sandy J; Delgoda R; Sim E; Noble ME
Nat Struct Biol; 2000 Jul; 7(7):560-4. PubMed ID: 10876241
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of arylamine N-acetyltransferases: insights into the mechanisms of action and substrate selectivity.
Kubiak X; Dairou J; Dupret JM; Rodrigues-Lima F
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):349-62. PubMed ID: 23289949
[TBL] [Abstract][Full Text] [Related]
18. An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
Brooke EW; Davies SG; Mulvaney AW; Pompeo F; Sim E; Vickers RJ
Bioorg Med Chem; 2003 Apr; 11(7):1227-34. PubMed ID: 12628650
[TBL] [Abstract][Full Text] [Related]
19. Arylamine N-acetyltransferases in prokaryotic and eukaryotic genomes: a survey of public databases.
Vagena E; Fakis G; Boukouvala S
Curr Drug Metab; 2008 Sep; 9(7):628-60. PubMed ID: 18781915
[TBL] [Abstract][Full Text] [Related]
20. Structure of Mesorhizobium loti arylamine N-acetyltransferase 1.
Holton SJ; Dairou J; Sandy J; Rodrigues-Lima F; Dupret JM; Noble ME; Sim E
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Jan; 61(Pt 1):14-6. PubMed ID: 16508079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
